Targeted delivery of mannosylated-PLGA nanoparticles of antiretroviral drug to brain

Mannosylated polymeric nanoparticles (NPs) enable improvement of brain bioavailability and reduction of dosing due to efficient drug delivery at the target site. Mannose receptors are present on the surface of macrophages, and therefore, in this study, it is expected that mannosylated NPs of anti-hu...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of nanomedicine Vol. 13; no. T-NANO 2014 Abstracts; pp. 97 - 100
Main Authors Patel, Bhavin K, Parikh, Rajesh H, Patel, Nilesh
Format Journal Article
LanguageEnglish
Published New Zealand Dove Medical Press 2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Mannosylated polymeric nanoparticles (NPs) enable improvement of brain bioavailability and reduction of dosing due to efficient drug delivery at the target site. Mannose receptors are present on the surface of macrophages, and therefore, in this study, it is expected that mannosylated NPs of anti-human immunodeficiency virus drug may target the macrophages, which may improve the therapeutic outcome and reduce the toxicity of antiretroviral bioactives. Poly(lactic-co-glycolic acid) (PLGA) and mannosylated-PLGA NPs (Mn-PLGA NPs) were prepared and administered by intravenous route in a dose of 10 mg/kg. After predetermined time period, the pharmacokinetics and biodistribution of NPs were analyzed using high-performance liquid chromatography and confocal microscopy, respectively. Results of this study indicated that Mn-PLGA NPs would be a promising therapeutic system for efficient delivery of the drug into brain macrophages.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1178-2013
1176-9114
1178-2013
DOI:10.2147/IJN.S124692